Yaobang Liu

Department of Surgical Oncology, General Hospital of Ningxia Medical University

Affiliated withGeneral Hospital of Ningxia Medical University

Research Area

Biography

Yaobang Liu has not added Biography.
If you are Yaobang Liu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 2	2025

Other Publications

Article	Year
[Expression of superoxide dismutase 2 in breast cancer and its clinical significance]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University\| PubMed ID: 32895185	2020
MicroRNA-1297 downregulation inhibits breast cancer cell epithelial-mesenchymal transition and proliferation in a FA2H-dependent manner. Oncology letters\| PubMed ID: 33014155	2020
Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer. Breast cancer (Tokyo, Japan)\| PubMed ID: 33108608	2021
DNA methyltransferase 1 inhibits microRNA-497 and elevates GPRC5A expression to promote chemotherapy resistance and metastasis in breast cancer. Cancer cell international\| PubMed ID: 35255904	2022
Exosomes Derived from Tumor Cells Initiate Breast Cancer Cell Metastasis and Chemoresistance through a MALAT1-Dependent Mechanism. Journal of oncology\| PubMed ID: 35813865	2022
Watson for oncology decision system for treatment consistency study in breast cancer. Clinical and experimental medicine\| PubMed ID: 36138331	2023
HINT3 suppresses AKT/mTOR signaling pathway activity during breast cancer tumorigenesis through PTEN transcriptional activation. International journal of molecular medicine\| PubMed ID: 37203409	2023
Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma. BMC pulmonary medicine\| PubMed ID: 37308925	2023
Knockdown of LINC00702 inhibits the growth and induces apoptosis of breast cancer through the Wnt/β-catenin pathway. Heliyon\| PubMed ID: 37860544	2023
Meta-analysis of quality of life in patients with cancer treated with antibody-drug conjugates in randomized controlled trials. Future oncology (London, England)\| PubMed ID: 37882431	2023
Treatment-related adverse events of antibody-drug conjugates in clinical trials: A systematic review and meta-analysis. Cancer innovation\| PubMed ID: 38090386	2023
Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction. American journal of clinical oncology\| PubMed ID: 38131531	2024
Survival nomogram for patients with metastatic breast cancer based on the SEER database and an external validation cohort. Cancer pathogenesis and therapy\| PubMed ID: 38327599	2023
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients. Breast cancer (Dove Medical Press)\| PubMed ID: 38476641	2024
Clinicopathological characteristics and prognostic factors in invasive micropapillary carcinoma of the breast. Archives of medical science : AMS\| PubMed ID: 38757040	2024
LncRNA TCL6 regulates miR-876-5p/MYL2 axis to suppress breast cancer progression. Translational oncology\| PubMed ID: 39874729	2025
The RNA-binding protein LARP6 regulates the alternative splicing of related genes in MDA-MB-231 cells. Scientific reports\| PubMed ID: 40050364	2025
Nomogram for predicting the risk and prognosis of lung metastasis of four subtypes of breast cancer: A population-based study from SEER. Cancer pathogenesis and therapy\| PubMed ID: 40182125	2025